The significance of a drug's existence in this world is something that everyone may have their own understanding of.
Pharmaceutical companies see the existence of drugs as their achievement, a cash cow, and want to squeeze out as much profit as possible.
Scientists believe this is a treasure bestowed upon humanity by nature, belonging to all humankind. Of course, not everyone has the means to obtain it, just as farming requires a harvest. Obtaining medicine also requires a price, but it is by no means something unattainable for most people.
Patients believe that the right to life is above all else. For the sake of their own lives, they have the right to take any means to obtain the medicine for treatment. Some patients even believe that the right to health is one of the inherent human rights. Regardless of wealth or social status, if they cannot afford it, then it is not their problem, but the problem of society.
Just like its molecular model, a drug has a complex three-dimensional structure, with each side being different.
Each person can only see one side of it, and therefore has their own interpretation.
After all, many medicines have indeed existed since ancient times. Most of them come from the embrace of nature, and their uses were only discovered by humans by chance hundreds or thousands of years ago. Who can monopolize such medicines?
With the rapid advancement of science and technology, medicine still possesses its own unique characteristics.
Its fundamental principles and discoveries all stem from the exploration of the human body.
Its important research requires clinical trials and human testing to be validated and to prove its usefulness.
Its ultimate purpose is to be used on people.
It comes from people, is taken from people, and is used for people.
It belongs to all of humanity.
In any case, at this moment, in the Biology Laboratory of Three Purities, Tang Que spoke his true feelings.
He uttered that resounding statement. "If no one can afford a medicine, it loses its meaning."
The applause was more thunderous than ever before.
Thunderous applause rang out wave after wave, the continuous and intense sound waves reverberating everywhere, as if trying to lift the high Smallpox off the ground.
Every scientific researcher will also deeply reflect on the significance of their work.
Perhaps they want to swim freely in the ocean of truth, perhaps they want to be remembered for generations, perhaps they want to gain recognition from their peers and the Volkswagen, perhaps they want to be crowned with the crown of fame and fortune.
However, in any case, this meaning will not be just about money.
When a scientist's work cannot be used, it loses its meaning and can only be blown away by the wind like a fallen leaf, disappearing into the dust of history.
Just like that Gene Therapy drug that was launched four years ago but only sold one unit, it ultimately failed to generate revenue and was withdrawn from the market.
This is certainly an outcome that no researcher wants to see.
Although, this result is quite reasonable.
If researchers had the authority, they would probably prefer to reduce the price of the drug to a level that patients can afford.
I also don't want to see my work completely wasted because of the price.
Pearls are covered in dust, and treasures sink to the bottom.
This is a loss for humanity and a waste of scientific research resources.
Since ancient times, China has had a tradition of valuing the people above all else, and every person who grows up on this land always has a compassionate heart.
The ideal of every China person is for everyone to be like a dragon.
Leaving no patient behind is also the ideal of China medicine practitioners.
Today, in Three Purities, they have found the same belief and gathered together for the same ideal.
How could one not tremble with fear and be shaken to their core?
Everyone was so excited that their faces were flushed, and loud cheers and applause rang out, interspersed with some whistles.
They've practically turned a serious workplace into a celebrity-chasing entertainment room.
Tang Que clapped his hands suddenly, and the scene immediately fell silent.
"Alright, I'm not asking you to do charity, so don't get so worked up. If the drugs I develop can't be sold, the boss will definitely kill me."
"Hehehe." Everyone let out a good-natured laugh.
"Of the three marketed drugs, Biogen's drug is already covered by medical insurance, and the price has come down, so we don't need to target it."
"Moreover, this drug also has its limitations. First, it does not cure the root cause; it mainly works by upregulating the expression level of neuronal survival protein (SMN protein) through messenger RNA (mRNA). Patients need to take the drug for life, and the administration method is very inhumane."
"Because the antisense oligonucleotides used in this drug do not easily cross the blood-brain barrier, it can only be administered intrathecally. Patients have to undergo lumbar puncture injections each time, and each injection can last for three months. I think we should be more particular about the method of administration and be more considerate of the patients."
"So let's take a look at the treatment methods and molecular mechanisms of action of the other two exorbitantly priced drugs."
"After all, if they can sell at such a high price and stubbornly refuse to lower it, they must have something special about them."
"And I enjoy conquering such opponents and taking on the highest level of difficulty."
"Next, let's analyze Novartis's 14 million RMB price tag drug and Roche's 100 million RMB price tag oral drug."
"As is well known, Spinal Muscular Atrophy (SMA) is a rare, inherited neuromuscular disease and a leading genetic cause of infant mortality. Its pathogenesis stems from the absence or abnormality of a protein called the survival motor neuron (SMN)."
"There are two genes in the human body that can produce SMN protein, namely the SMN1 gene and the SMN2 gene, but the SMN1 gene plays a dominant role, while the SMN2 gene only produces a small amount of SMN protein, about 10%."
"Once the SMN1 gene malfunctions, patients may not be able to produce enough SMN, which can affect their movement, breathing, swallowing, and multiple organs such as the spleen, heart, and pancreas, and may even threaten their lives."
"Based on the degree of SMN protein deficiency, SMA can be classified into several types. Among them, the most severe type I SMA patients usually die within 24 months or require permanent respiratory support due to rapid neuronal death and muscle damage."
"Based on the pathogenesis, there are two different approaches to the treatment of SMA. One is to target the SMN1 gene, which involves directly introducing the gene that encodes the normal SMN1 through a vector. This is the Gene Therapy used in Novartis' Z drug."
"The second method targets the SMN2 gene, promoting the normal expression of SMN2 in the patient's body to achieve the production of SMN protein. This is Roche's oral liquid drug E."
"In theory, SMN1 gene replacement therapy is one of the most reasonable and effective methods for treating Spinal Muscular Atrophy, with the advantage that clinical efficacy can be achieved with just a single intravenous injection."
"Novartis' Z is such a drug that the Gene: An Intimate History to muscle cells, enabling the production of SMN protein. The defective SMN1 gene is not removed and may continue to be transcribed, producing unknown downstream effects."
"This treatment is like getting a vaccine. It uses a relatively safe viral vector to introduce the correct SMN1 gene into the host's body, thereby infecting motor Neurons and enabling new cells to produce SMN protein. Just one injection is enough for the patient's body to continuously produce SMN protein, thus curing the disease in a sense."
"Of course, the second method is also very good. By regulating the cleavage of SMN2 gene mRNA through small molecule binders, the mRNA level of normal SMN protein can be expressed, thereby alleviating the symptoms of SMA patients."
"It requires dosage based on the patient's weight and needs to be taken continuously, which makes it an ideal drug for pharmaceutical companies. Patients are like a money tree, providing a continuous stream of income. Logically, such a drug should be affordable for people; otherwise, what's the point?"
"After all, it's not like Novartis's Z drug, which solves everything once and for all and eliminates future problems. At least that one injection cures the disease, so there's a reason why it's more expensive."
"Who gave them the audacity to sell this medication at such a high price, which requires lifelong use? Don't they understand the principle of sustainable growth, and instead want to kill the goose that lays the golden eggs?"
"I can't stand this kind of arrogance. Next, we will take a two-pronged approach and develop our own unique drug by working on both of these approaches."
Tang Que explained these contents in detail, making them clear and easy to understand.
Everyone understood their goals and the direction of their efforts.